The new smart body area networks standard establishes standardized service and application interfaces and facilitators, API (Application Programming Interfaces) and infrastructure for interoperability management and offers secure interaction and access to any SmartBAN data or entities.
The architecture is provided with cross-functional components for allowing non SmartBAN enabled environments to interoperate with SmartBAN and AddressesNetwork, syntactic, informational and semantic interoperability.
The Novartis generics business is taking on digital and data technologies from discovery and development all the way to commercialization, believing the approach can open up healthcare access and improve patient outcomes.
Leading the digital transformation push in North America is Carol Lynch, president of Sandoz U.S. and head of North America, and Mike Fraser, VP of strategy, innovation and analytics.
The two talked to FiercePharma recently about Sandoz and Novartis’ strategy, programs and mission in digital technology.